NO20075406L - Pyrimidindionerivater som prokineticin-2-reseprorantagonister - Google Patents
Pyrimidindionerivater som prokineticin-2-reseprorantagonisterInfo
- Publication number
- NO20075406L NO20075406L NO20075406A NO20075406A NO20075406L NO 20075406 L NO20075406 L NO 20075406L NO 20075406 A NO20075406 A NO 20075406A NO 20075406 A NO20075406 A NO 20075406A NO 20075406 L NO20075406 L NO 20075406L
- Authority
- NO
- Norway
- Prior art keywords
- prokineticin
- receptor antagonists
- dione derivatives
- pyrimidine dione
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66486505P | 2005-03-24 | 2005-03-24 | |
| PCT/US2006/009607 WO2006104713A1 (fr) | 2005-03-24 | 2006-03-14 | Derives de pyrimidindione tenant lieu d'antagonistes du recepteur de la prokineticine 2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20075406L true NO20075406L (no) | 2007-12-14 |
Family
ID=36580484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20075406A NO20075406L (no) | 2005-03-24 | 2007-10-23 | Pyrimidindionerivater som prokineticin-2-reseprorantagonister |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080045535A1 (fr) |
| EP (1) | EP1869006A1 (fr) |
| JP (1) | JP2008534499A (fr) |
| KR (1) | KR20070116915A (fr) |
| CN (1) | CN101223147A (fr) |
| AR (1) | AR053700A1 (fr) |
| AU (1) | AU2006229791A1 (fr) |
| BR (1) | BRPI0609317A2 (fr) |
| CA (1) | CA2602510A1 (fr) |
| EA (1) | EA200702062A1 (fr) |
| IL (1) | IL186188A0 (fr) |
| MX (1) | MX2007011847A (fr) |
| NO (1) | NO20075406L (fr) |
| TW (1) | TW200716566A (fr) |
| WO (1) | WO2006104713A1 (fr) |
| ZA (1) | ZA200709147B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006004712A2 (fr) | 2004-06-29 | 2006-01-12 | United States Postal Service | Unite de batterie de boites aux lettres comportant des elements de securite |
| CA2602576A1 (fr) | 2005-03-24 | 2006-10-05 | Janssen Pharmaceutica N.V. | Antagonistes du recepteur de prokineticine 1 |
| CA2630517A1 (fr) * | 2005-12-06 | 2007-06-14 | Merck & Co., Inc. | Antagonistes de recepteur de prokineticine de morpholine-carboxamide |
| CN101495464B (zh) * | 2005-12-29 | 2014-03-05 | 詹森药业有限公司 | 激肽原1受体拮抗剂 |
| CN101405002A (zh) * | 2005-12-29 | 2009-04-08 | 詹森药业有限公司 | 激肽原2受体拮抗剂 |
| US8324380B2 (en) * | 2007-10-30 | 2012-12-04 | Janssen Pharmaceutica Nv | Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| WO2010077976A2 (fr) * | 2008-12-17 | 2010-07-08 | The Regents Of The University Of California | Antagoniste du récepteur de la prokinéticine et ses utilisations |
| CA2752269C (fr) * | 2009-02-13 | 2016-08-30 | Hiroyuki Kai | Nouveau derive de triazine et composition pharmaceutique le contenant |
| BRPI1013561A8 (pt) * | 2009-03-26 | 2015-09-22 | Mapi Pharma Ltd | processo para a preparação de alogliptina |
| CA2803545A1 (fr) * | 2010-06-28 | 2012-01-12 | Janssen Pharmaceutica Nv | Antagonistes du recepteur-1 de la prokineticine pour le traitement de la douleur |
| US20110319418A1 (en) * | 2010-06-28 | 2011-12-29 | Flores Christopher M | Prokineticin 1 receptor antagonists for the treatment of pain |
| WO2012020749A1 (fr) | 2010-08-10 | 2012-02-16 | 塩野義製薬株式会社 | Dérivé de triazine et composition pharmaceutique présentant une activité analgésique à teneur en dérivé de triazine |
| JP6075621B2 (ja) | 2010-08-10 | 2017-02-08 | 塩野義製薬株式会社 | 新規複素環誘導体およびそれらを含有する医薬組成物 |
| WO2013118855A1 (fr) | 2012-02-09 | 2013-08-15 | 塩野義製薬株式会社 | Noyau hétérocyclique et dérivé carbocyclique |
| TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
| WO2015099107A1 (fr) | 2013-12-26 | 2015-07-02 | 塩野義製薬株式会社 | Dérivé cyclique à six chaînons contenant de l'azote et composition pharmaceutique le contenant |
| WO2016171249A1 (fr) | 2015-04-24 | 2016-10-27 | 塩野義製薬株式会社 | Dérivé hétérocyclique à 6 chainons et composition pharmaceutique comprenant celui-ci |
| CA3039458A1 (fr) | 2016-10-17 | 2018-04-26 | Shionogi & Co., Ltd. | Derive heterocyclique azote bicyclique et composition pharmaceutique le comprenant |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9704272D0 (sv) * | 1997-11-21 | 1997-11-21 | Astra Pharma Prod | Novel Compounds |
| AU2003249535A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| WO2004014868A2 (fr) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Derives de pyrimidine 2,4-diones, utilises comme inhibiteurs de metalloproteinase matricielle |
-
2006
- 2006-03-14 BR BRPI0609317-5A patent/BRPI0609317A2/pt not_active IP Right Cessation
- 2006-03-14 KR KR1020077024511A patent/KR20070116915A/ko not_active Application Discontinuation
- 2006-03-14 CA CA002602510A patent/CA2602510A1/fr not_active Abandoned
- 2006-03-14 US US11/375,242 patent/US20080045535A1/en not_active Abandoned
- 2006-03-14 EP EP06738643A patent/EP1869006A1/fr not_active Withdrawn
- 2006-03-14 JP JP2008503044A patent/JP2008534499A/ja not_active Withdrawn
- 2006-03-14 WO PCT/US2006/009607 patent/WO2006104713A1/fr active Application Filing
- 2006-03-14 AU AU2006229791A patent/AU2006229791A1/en not_active Abandoned
- 2006-03-14 MX MX2007011847A patent/MX2007011847A/es unknown
- 2006-03-14 EA EA200702062A patent/EA200702062A1/ru unknown
- 2006-03-14 CN CNA2006800177908A patent/CN101223147A/zh active Pending
- 2006-03-23 TW TW095109981A patent/TW200716566A/zh unknown
- 2006-03-23 AR ARP060101154A patent/AR053700A1/es not_active Application Discontinuation
-
2007
- 2007-09-23 IL IL186188A patent/IL186188A0/en unknown
- 2007-10-23 ZA ZA200709147A patent/ZA200709147B/xx unknown
- 2007-10-23 NO NO20075406A patent/NO20075406L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20080045535A1 (en) | 2008-02-21 |
| EA200702062A1 (ru) | 2008-02-28 |
| WO2006104713A1 (fr) | 2006-10-05 |
| ZA200709147B (en) | 2009-08-26 |
| EP1869006A1 (fr) | 2007-12-26 |
| CN101223147A (zh) | 2008-07-16 |
| AU2006229791A1 (en) | 2006-10-05 |
| AR053700A1 (es) | 2007-05-16 |
| IL186188A0 (en) | 2008-01-20 |
| BRPI0609317A2 (pt) | 2010-03-16 |
| JP2008534499A (ja) | 2008-08-28 |
| KR20070116915A (ko) | 2007-12-11 |
| MX2007011847A (es) | 2008-03-11 |
| TW200716566A (en) | 2007-05-01 |
| CA2602510A1 (fr) | 2006-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075406L (no) | Pyrimidindionerivater som prokineticin-2-reseprorantagonister | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| NO20060202L (no) | Pyrrolodihydroisokinoliner som PDE-10-inhibitorer | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| NO20083909L (no) | Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| NO20045589L (no) | Nye forbindelser | |
| NO20070855L (no) | Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer. | |
| EA201190158A1 (ru) | Производные бензофуранила для применения в качестве ингибиторов глюкокиназы | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| EA201100311A1 (ru) | Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы | |
| NO20070249L (no) | Pyrrazolo-pyrimidin derivater | |
| NO20070336L (no) | Indolderivater som histamin-reseptorantagonister | |
| MY153719A (en) | Prokineticin 1 receptor antagonists | |
| NO20065678L (no) | 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer. | |
| NO20055465L (no) | Imidazolderivater som glutamatreseptorantagonister | |
| WO2006100081A3 (fr) | Derives d'indoxyle substitues, medicaments les contenant et leur utilisation | |
| WO2007079163A3 (fr) | Antagonistes du recepteur de la prokineticine 1 | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| NO20082285L (no) | 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer | |
| NO20090266L (no) | Piperazinylderivater anvendelige i behandlingen av GPR38 receptormedierte sykdommer | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| NI200700032A (es) | Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas | |
| MX2010001093A (es) | Herbicidas novedosos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |